RotateHydrogensLabels

CCS

CARBOXYMETHYLATED CYSTEINE


View summary at Ligand Expo



Chemical Component Summary

NameCARBOXYMETHYLATED CYSTEINE
Identifiers(2R)-2-amino-3-(carboxymethylsulfanyl)propanoic acid
FormulaC5 H9 N O4 S
Molecular Weight179.19
TypeL-PEPTIDE LINKING
Isomeric SMILESN[C@@H](CSCC(O)=O)C(O)=O
InChIInChI=1S/C5H9NO4S/c6-3(5(9)10)1-11-2-4(7)8/h3H,1-2,6H2,(H,7,8)(H,9,10)/t3-/m0/s1
InChIKeyGBFLZEXEOZUWRN-VKHMYHEASA-N

Chemical Details

Formal Charge0
Atom Count20
Chiral Atom Count1
Bond Count19
Aromatic Bond Count0

Drug Info: DrugBank

DrugBank IDDB04339 
NameCarbocisteine
Groups
  • approved
  • investigational
DescriptionCarbocisteine is a mucolytic that reduces the viscosity of sputum to relieve the symptoms of chronic obstructive pulmonary disorder (COPD) and bronchiectasis through easier expulsion of mucus. Carbocisteine should not be used with antitussives (cough suppressants) or medicines that dry up bronchial secretions as they are functional antagonists. Carbocisteine is produced by alkylation of cysteine with chloroacetic acid.
Synonyms
  • (R)-S-(carboxymethyl)cysteine
  • carbocisteína
  • L-3-((carboxymethyl)thio)alanine
  • S-carboxymethyl-L-cysteine
  • S-carboxymethylcysteine
IndicationUsed to help relieve the symptoms of chronic obstructive pulmonary disorder (COPD) and bronchiectasis.
Categories
  • Cough and Cold Preparations
  • Expectorants
ATC-CodeR05CB03
CAS number638-23-3

Drug Targets

NameTarget SequencePharmacological ActionActions
Glutathione S-transferase PMPPYTVVYFPVRGRCAALRMLLADQGQSWKEEVVTVETWQEGSLKASCLY...unknown
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
PubChem193653
ChEBICHEBI:16163
ChEMBLCHEMBL396416